CPT code 14301 denotes a local tissue replacement procedure for defects sized 30.1 cm2 to 60.0 cm2, used when lesions are excised and adjacent healthy tissue is mobilized to close the defect. This reconstructive technique is clinically significant across specialties including plastic surgery, dermatologic surgery, and surgical oncology because it balances defect closure with tissue preservation and functional outcomes. Nationally, utilization of such flap and local advancement procedures is relevant for hospital surgical planning, ambulatory surgical center workflows, and payer coverage policies.

Key payers included in the discussion are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will encounter a concise overview of the code’s clinical intent and service profile, typical sites of service, and the payer landscape relevant to reimbursement and claim adjudication. The publication also provides benchmarks for utilization, notes on documentation elements that commonly influence coverage decisions, and contextual clinical considerations for defect size and technique selection. Where input data is missing, the text notes availability limitations. The summary is intended for revenue cycle leaders, surgical providers, and policy analysts seeking a national perspective on coding, clinical context, and payer coverage patterns for CPT code 14301.